Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
15 July 2022
Closing Date:
30 September 2024
Location(s):
DE DEUTSCHLAND (DE Germany/DEUTSCHLAND)
Description:
Contracts are available for various pharmaceutical products under an open-house procedure, allowing pharmaceutical companies to join a discount contract for specific active ingredients until 30.11.2024.
Various open house contracts

Open house contracts for various active ingredients until 30.11.2024.

Metformin, ATC-Code: A10BA02

The subject of this publication is the conclusion of contracts in accordance with Section 130a (8) SGB V for various active substances in the context of a so-called open-house procedure. Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies will be able to conclude or join a

Discount contract according to § 130a Abs. 8 SGB V offered for the mentioned active ingredient. The earliest contract start is 01.10.2022, contract end is 30.11.2024. It is possible to join this open house procedure at any time within the term of the contract.

Metformin-Sitagliptin, ATC-Code: A10BD07

The subject of this publication is the conclusion of contracts in accordance with Section 130a (8) SGB V for various active substances in the context of a so-called open-house procedure. Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies will be able to conclude or join a

Discount contract according to § 130a Abs. 8 SGB V offered for the mentioned active ingredient. The earliest contract start is 01.10.2022, contract end is 30.11.2024. It is possible to join this open house procedure at any time within the term of the contract.

Metoprolol, ATC-Code: C07AB02

The subject of this publication is the conclusion of contracts in accordance with Section 130a (8) SGB V for various active substances in the context of a so-called open-house procedure. Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies will be able to conclude or join a

Discount contract according to § 130a Abs. 8 SGB V offered for the mentioned active ingredient. The earliest contract start is 01.10.2022, contract end is 30.11.2024. It is possible to join this open house procedure at any time within the term of the contract.

Sitagliptin, ATC-Code: A10BH01

The subject of this publication is the conclusion of contracts in accordance with Section 130a (8) SGB V for various active substances in the context of a so-called open-house procedure. Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies will be able to conclude or join a

Discount contract according to § 130a Abs. 8 SGB V offered for the mentioned active ingredient. The earliest contract start is 01.10.2022, contract end is 30.11.2024. It is possible to join this open house procedure at any time within the term of the contract.

Download full details as .pdf
The Buyer:
AOK Bremen/Bremerhaven
CPV Code(s):
33600000 - Pharmaceutical products